Aurora B — Drug Target
All drugs that target Aurora B — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 1 pipeline (1)
- AZD1152 part B · AstraZeneca · Aurora kinase inhibitor · Oncology
AZD1152 is a selective Aurora B kinase inhibitor that disrupts mitotic progression and leads to cell cycle arrest and apoptosis in cancer cells.